Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1998
05/20/1998EP0842428A1 Process for producing gm2 specific antibodies
05/20/1998EP0842291A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0842284A1 Recombinant protein having bacteriophage endosialidase enzymatic activity
05/20/1998EP0842273A2 Receptor ligand vegf-c
05/20/1998EP0842193A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
05/20/1998EP0842186A1 Cross-linking oligonucleotides
05/20/1998EP0842185A1 Improved therapeutic agents
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0842151A1 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
05/20/1998EP0842150A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors
05/20/1998EP0841953A1 Method and apparatus for interstitial radiation of the prostate gland
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841940A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
05/20/1998EP0841939A1 Therapeutic agents and autoimmune diseases
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841924A1 Benzimidazole compounds
05/20/1998EP0841921A2 Use of fluconazole for inhibiting the growth of cancers
05/20/1998EP0841920A2 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
05/20/1998EP0841919A1 Inhibitors of farnesyl-protein transferase
05/20/1998EP0841914A2 Use of griseofulvin for inhibiting the growth of cancers
05/20/1998EP0841912A1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0643690B1 Desferrioxamine-b salts and their use as orally effective iron chelators
05/20/1998CN1182430A Carbohydrate conjugated bio-active compounds
05/20/1998CN1182421A Quinazoline derivatives
05/20/1998CN1182371A Formulations for lipophilic compounds
05/20/1998CN1182370A Vaccines containing saponin and sterol
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders
05/20/1998CN1182087A New substituted 7, 12 -dioxabenz £a| anthracene compounds, process for preparing them and pharmaceutical compositions containing them
05/20/1998CN1182086A New bisimide compounds, process for preparing them and pharmaceutical compositions containing them
05/19/1998US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753668 Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase
05/19/1998US5753650 Inhibitors of farnesyl-protein transferase
05/19/1998US5753629 Amino acid derivative antibiotics; viricides
05/19/1998US5753618 Somatostatin analogue composition and use in treating breast cancer
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753432 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
05/19/1998US5753230 Methods and compositions useful for inhibition of angiogenesis
05/19/1998US5753204 Imaging antigens, polypeptides and binding
05/19/1998CA2007507C Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020135A2 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998WO1998020132A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998WO1998020128A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998WO1998020127A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998WO1998020126A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/14/1998WO1998020117A1 Prostate-specific kallikrein
05/14/1998WO1998020032A1 Sprouty protein and coding sequence
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020013A1 New knoevenagel condensation products, method for their production and their use
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019712A1 Methods for regulating angiogenesis
05/14/1998WO1998019705A1 Branched peptide linkers
05/14/1998WO1998019667A1 Sustained release formulation containing dfmo
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998019541A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998006864A3 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005684A3 Mhc binding peptide oligomers and methods of use
05/14/1998WO1998003654A3 High-affinity interleukin-4 muteins
05/14/1998WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor
05/14/1998CA2271291A1 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998CA2271203A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells
05/14/1998CA2270973A1 New knoevenagel condensation products, method for their production and their use
05/14/1998CA2270291A1 Prostate-specific kallikrein
05/14/1998CA2270173A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998CA2269665A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998CA2269641A1 Sprouty protein and coding sequence
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/14/1998CA2264610A1 Branched peptide linkers
05/14/1998CA2263199A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998CA2241896A1 Sustained release formulation containing dfmo
05/14/1998CA2239463A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841396A1 Human telomerase catalytic subunit
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0841337A1 Substituted 7,12-dioxabenzo(a)anthracene derivatives, process for their preparation and pharmaceutical compositions containing them
05/13/1998EP0840791A2 Generation of immune responses to prostate-specific antigen (psa)
05/13/1998EP0840750A1 Ha-2 antigenic peptide
05/13/1998EP0840738A1 Colchicine derivatives, the use thereof and formulations containing them
05/13/1998EP0840729A1 Inhibitors of phospholipase a 2?
05/13/1998EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0840605A1 Compounds useful in the treatment of neurofibromatosis
05/13/1998EP0840604A1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
05/13/1998EP0599881B1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
05/13/1998CN1181706A Arteriovenous and venous graft treatments: methods and compsns.
05/13/1998CN1181701A Pharmaceutical compsn. containing N-chlorophenylcar-bamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses andcancers
05/13/1998CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/13/1998CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor
1 ... 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 ... 2211